All reports
Public comment
CY 2027 OPPS Final Rule
Drug pricing data
Machine-readable files (MRF)

Turquoise's Public Comment on CMS-1850-P

Turquoise's Public Comment on CMS-1850-P
Download PDF

Related resources

Learn, listen, and watch the latest on price transparency.

View all
Turquoise's public comment on CMS 9882-P
Transparency in Coverage (TiC)
2/23/26

Turquoise's public comment on CMS 9882-P

Transparency in Coverage files are on the verge of a much-needed overhaul to become leaner, more organized, and more useful.

Turquoise's public comment on CMS-1834-P
Public comment
9/15/25

Turquoise's public comment on CMS-1834-P

Turquoise Health's public comment on CMS-1834-P supporting comprehensive hospital MRF standards, seeking clarification on new percentile fields, and providing recommendations on EDI 835 ERA transaction data utility. Read our full analysis.

2025 drug reimbursement trends report
Drug pricing data
9/9/25

2025 drug reimbursement trends report

Turquoise Health and ZS's 2025 drug reimbursement trends report analyzes millions of hospital and payer-reported drug rates across 17 products and 4 therapeutic areas revealing how payer-provider dynamics drive reimbursement from 3× to 10× ASP. Explore the data.